CDNA(CDNA)
CDNA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $456M | $481M | $507M |
| Low | $456M | $481M | $493M |
| High | $456M | $482M | $516M |
| EBITDA Avg | $-60M | $-64M | $-67M |
| Low | $-60M | $-64M | $-68M |
| High | $-60M | $-64M | $-65M |
| EBIT Avg | $-85M | $-90M | $-95M |
| Low | $-85M | $-90M | $-97M |
| High | $-85M | $-90M | $-92M |
| Net Income Avg | $49M | $60M | $81M |
| Low | $48M | $58M | $79M |
| High | $51M | $62M | $83M |
| EPS Avg | $0.93 | $1.13 | $1.53 |
| Low | $0.90 | $1.09 | $1.47 |
| High | $0.96 | $1.16 | $1.56 |
| Analysts (Rev / EPS) | 5 / 3 | 5 / 3 | 2 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $114M | $111M | $113M | $113M | $117M | $119M | $124M |
| Low | $113M | $111M | $111M | $111M | $115M | $117M | $122M |
| High | $115M | $112M | $114M | $115M | $118M | $121M | $126M |
| EBITDA Avg | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M |
| Low | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M |
| High | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M |
| EBIT Avg | $-21M | $-21M | $-21M | $-21M | $-22M | $-22M | $-23M |
| Low | $-21M | $-21M | $-21M | $-21M | $-22M | $-23M | $-24M |
| High | $-21M | $-21M | $-21M | $-21M | $-22M | $-22M | $-23M |
| Net Income Avg | $12M | $10M | $9M | $12M | $14M | $15M | $17M |
| Low | $12M | $10M | $9M | $12M | $14M | $14M | $17M |
| High | $13M | $10M | $9M | $12M | $14M | $15M | $17M |
| EPS Avg | $0.23 | $0.19 | $0.17 | $0.23 | $0.26 | $0.28 | $0.32 |
| Low | $0.23 | $0.18 | $0.17 | $0.22 | $0.26 | $0.27 | $0.31 |
| High | $0.24 | $0.19 | $0.17 | $0.23 | $0.27 | $0.28 | $0.32 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 |